These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2284757)

  • 1. [The prostacyclin-thromboxane system and the functional properties of the thrombocytes in patients of different ages with ischemic heart disease].
    Ermakovich II; Ladnyĭ AI; Volkov VI; Tseluĭko VI
    Vrach Delo; 1990 Sep; (9):25-8. PubMed ID: 2284757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of nitrates and miskleron on the prostacyclin-thromboxane ratio and on the functional activity of the thrombocytes in stenocardia patients].
    Volkov VI; Ladnyĭ AI
    Vrach Delo; 1989 Nov; (11):60-2. PubMed ID: 2514486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prostacyclin-thromboxane system and thrombocytic-vascular hemostasis in patients with ischemic heart disease in the preoperative period].
    Abbakumov VV; Vinnitskiĭ LI; Kattakhanova RIu; Studennikova LN; Egorova IA; Smirnova LA
    Anesteziol Reanimatol; 1992; (1):42-4. PubMed ID: 1524251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
    Khimenko PL
    Ter Arkh; 1986; 58(5):95-8. PubMed ID: 2874621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered sensitivity to prostacyclin may be involved in the exercise-induced activation of platelets in patients with ischemic heart disease.
    Kishi Y; Numano F; Oniki T; Yajima M; Numano F
    Prog Clin Biol Res; 1989; 301():181-5. PubMed ID: 2508101
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of the calcium antagonist diltiazem on the prostacyclin-thromboxane ratio in the plasma of ischemic heart disease patients].
    Brovkovich VM; Topchiĭ II; Abidov AA
    Vopr Med Khim; 1991; 37(2):37-9. PubMed ID: 1897189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of physical load on the platelet function and ultrastructure in patients with ischemic heart disease.
    Oral I; Hrcková Y; Frysák Z; Kamarád V
    Acta Univ Palacki Olomuc Fac Med; 1992; 133():39-41. PubMed ID: 1344596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct].
    Aliavi AL
    Vrach Delo; 1988 Mar; (3):42-4. PubMed ID: 3293319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostacyclin-thromboxane system in children and adolescents with a high risk of developing ischemic heart disease].
    Akimova EV
    Vopr Med Khim; 1992; 38(2):47-9. PubMed ID: 1413633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocyte function in physical exertion and induced myocardial ischemia in patients with ischemic heart disease].
    Shalaev SV; Panchenko EP; Karasev AV; Pisareva NA; Ovtrakht NV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):28-33. PubMed ID: 3426815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocytic-vascular hemostasis at rest and under physical loading in patients with ischemic heart disease].
    Mingazetdinova LN; Shaĭmukhametova LT
    Kardiologiia; 1993; 33(3):12-4. PubMed ID: 8377329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and ischemic heart disease.
    Weiss HJ
    N Engl J Med; 1980 Jan; 302(4):225-6. PubMed ID: 7350464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neurohumoral and functional determinants of destabilization in patients with acute forms of ischemic heart disease].
    Tashchuk VK; Savitskiĭ SIu; Shumakov VA; Popova LI; Malinovskaia IE; Reĭko MN
    Vrach Delo; 1991 Jun; (6):28-30. PubMed ID: 1832506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
    Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):294-304. PubMed ID: 6363769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.